2018
DOI: 10.15761/fmc.1000101
|View full text |Cite
|
Sign up to set email alerts
|

Joint Laxity/Hypermobility: Old Problems and New Opportunities for Family Medicine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 12 publications
0
5
0
Order By: Relevance
“…Joint laxity or hypermobility is an important symptom in soft tissue pathologies [13]. The main cause of joint laxity is genetic factors.…”
Section: Discussionmentioning
confidence: 99%
“…Joint laxity or hypermobility is an important symptom in soft tissue pathologies [13]. The main cause of joint laxity is genetic factors.…”
Section: Discussionmentioning
confidence: 99%
“…Novel association of genes with disease through genomic analyses unbiased by symptomatic targeting is particularly enlightening for complex, common, and multifactorial disorders like autism (Wilson and Tonk, 2018) or EDS (Wilson, 2018). Problems compromising the application of these remarkable genome-screening technologies include the interpretation of molecular change as well as its key complement, the matching of DNA variants with appropriate disease entities.…”
Section: Discussionmentioning
confidence: 99%
“…Joint laxity or hypermobility is another biomarker of CTD, mainly the Type I (gravis type) and Type II (mitis type) EDS, Down's syndrome, Marfan syndrome, osteogenesis imperfecta, and benign joint hypermobility syndrome [40]. The joint laxity is maximal at birth, declining rapidly during childhood, less rapidly during the teens, and more slowly during adult life.…”
Section: Ctdsmentioning
confidence: 99%